Scalper1 News
Animal-health giant Zoetis (ZTS) saw its shares hit a more-than-two-month high Tuesday after it beat Wall Street’s Q3 earnings estimates and announced the acquisition of a fish-medicine company late Monday. Zoetis said Q3 earnings rose 22% over the year-earlier quarter to 50 cents a share, excluding one-time items, beatings analysts’ consensus by 10 cents, according to Thomson Reuters. Revenue was flat at $1.21 billion, about $40 million above the Scalper1 News
Scalper1 News